Skip to content

A Multi-Center Clinical Trial of the value of NGAL on diagnostic and prognosis evaluation of cardiorenal syndrome and severe infection disease

A Multi-Center Clinical Trial of the value of NGAL on diagnostic and prognosis evaluation of cardiorenal syndrome and severe infection disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-15006324
Enrollment
Unknown
Registered
2015-04-29
Start date
2015-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiac renal syndrome and sepsis

Interventions

Case series:NA

Sponsors

Beijing Chaoyang Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: The Heart Failure Group: Selection the patients who is clinical diagnosed acute heart failure (including the in-hospital patients and the new attendance patients), and meet anyone of the followings: The cardiac function of NYHA class III - IV and the value of NT – proBNP over the positive cut-off values of different age (the patients less than 50 years old of 450 pg/ml; 50-75 years old of 900 pg/ml; more than 75 year old of 1800 pg/ml). The cardiac function of Killip class III - IV after acute myocardial infarction and the value of NT – proBNP over the positive cut-off values of different age (the patients less than 50 years old of 450 pg/ml; 50-75 years old of 900 pg/ml; more than 75 year old of 1800 pg/ml). Echocardiographyof LVEF 38.3 degree C); Hypothermia (core temperature 90 bpm or more than 2 SDs above the normal value for age; Tachypnea; Altered mental status; Significant edema or positive fluid balance (>20 ml/kg during 24h); Hyperglycemia (plasma glucose >7.7mmol/L) in the absence of diabetes; Inflammatory Variables: Leukocytosis (WBC >12*10^9/L); Leukopenia (WBC 10% immature forms; Plasma C-reactive protein more than 2 SDs above the normal value; Plasma procalcitonin more than 2 SDs above the normal value. Hemodynamic Variables: Arterial hypotension (SBP 40 mmHg in adults or less than 2 SDs below normal for age); Organ Dysfunction Variables: Arterial hypoxemia (PaO2/FiO2 0.5 mg/dl; Coagulation abnormalities (INR>1.5or APTT>60s); Ileus (absent bowel sounds); Thrombocytopenia (platelet count 70umol/L). Tissue perfusion Variables: Hyperlactatemia (>1mmol/L); Decreased capillary refill or mottling.

Exclusion criteria

Exclusion criteria: The Heart Failure Group: Comply with anyone of the followings: Age <18 years old; Pregnancy; The abnormal renal function of known; Autoimmune diseases; Terminal cancer; Sepsis; The treatment time in emergency <3 days. The Sepsis Group: Comply with anyone of the followings: Age <18 years old; Pregnancy; The abnormal renal function of known; Autoimmune diseases; Terminal cancer; The treatment time in emergency <3 days.

Design outcomes

Primary

MeasureTime frame
Neutrophil Gelatinase-Associated Lipocalin;

Secondary

MeasureTime frame
Cystatin C;N - brain natriuretic peptide precursor;Procalcitonin;

Countries

China

Contacts

Public ContactChun-sheng Li
lcscyyy@163.com+86 13681392380

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026